Data elements, definitions for COVID-19 complications detailed
Jun 27, 2022
The clinical lexicon presents data elements related to cardiovascular and noncardiovascular complications of COVID-19.
ADA: Diabetes may quadruple risk for long COVID
Jun 08, 2022
The authors say that the review findings are limited by heterogenous definitions of long COVID in published studies.
mRNA COVID-19 vaccine less protective in elderly with comorbidity
Dec 23, 2021
At ≥7 days after the second dose, the effectiveness of mRNA COVID-19 vaccine was 69% against infection and 86% against related death.
Sotrovimab cuts risk for COVID-19 progression in high-risk patients
Oct 28, 2021
An interim analysis shows a lower risk for progression with sotrovimab versus placebo among high-risk patients with mild-to-moderate COVID-19.
Dexamethasone underused for adults hospitalized with COVID-19
Aug 16, 2021
Dexamethasone and remdesivir use gradually have increased during the pandemic; hydroxychloroquine use peaked in March 2020.
Most with reaction to mRNA COVID-19 vaccine tolerate second dose
Jul 29, 2021
Most patients with an immediate, potentially allergic reaction to Pfizer-BioNTech or Moderna mRNA COVID-19 vaccine tolerate a second dose
3 in 4 retirees say means to a comfortable lifestyle have stayed the same during pandemic
By
Amy Novotney
Sep 08, 2020
Here’s some good news for the senior housing industry: Despite the ongoing pandemic, 75% of retirees say their confidence in their ability to maintain a comfortable lifestyle through retirement has stayed...
Fluvoxamine does not improve time to sustained recovery in mild COVID-19
Jan 12, 2023
No difference was seen for fluvoxamine or placebo in composite outcome of hospitalization, urgent care visit, emergency department visit and death.
Nirmatrelvir plus ritonavir reduces risks for COVID-19 in seniors
Dec 12, 2022
Reduced risks for hospitalization and death were observed for mainly vaccinated outpatients aged 50 years or older with COVID-19.
Theophylline nasal irrigation studied in COVID-19-related smell loss
Jul 29, 2022
In a phase 2 trial, subjective assessments suggest improvement in COVID-19-related olfactory dysfunction, but the study results were inconclusive.